Eradication and reinfection of human papillomavirus after photodynamic therapy for cervical intraepithelial neoplasia

Int J Clin Oncol. 2003 Oct;8(5):322-5. doi: 10.1007/s10147-003-0354-4.

Abstract

Background: Photodynamic therapy (PDT) has been proven to be a promising therapeutic modality for selected dysplasias and malignancies in a variety of organs. We assessed the effectiveness of PDT for treating cervical intraepithelial neoplasia (CIN) by cytological and histological examinations and investigated its impact on human papillomavirus (HPV) infection.

Methods: A series of 31 patients with CIN (2 with CIN2, 29 with CIN3) were given polyhematoporphyrin ether/ester (PHE) 2 mg/kg IV. After 60 h their cervices were exposed to a 630-nm YAG-OPO laser. HPV-DNA extracted from cervical smears was amplified by the polymerase chain reaction and typed for HPV using restriction fragment length polymorphism.

Results: At 3 months after PDT, cytology and directed biopsy of the cervix revealed regression of the disease in 28 [complete remission (CR) rate 90%] of 31 patients, and HPV-DNA could be no longer detected in the cervical smears of 22 (76%) of 29 HPV-positive patients. After 12 months, all 31 patients had achieved a CR on biopsy, although HPV-DNA was still present in the cervical smears of 6 patients. The types of HPV-DNA detected 12 months after PDT were different from those seen before PDT in each of the 6 patients, suggesting that they might be reinfected with other HPV types after PDT.

Conclusion: PDT is effective not only in improving the cytological and histological measures when treating CIN but also for eradicating cervical HPV.

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use
  • Antiviral Agents / therapeutic use
  • Cervix Uteri / virology
  • DNA, Viral / analysis
  • Dihematoporphyrin Ether / therapeutic use
  • Female
  • Humans
  • Papillomaviridae / isolation & purification*
  • Papillomavirus Infections / drug therapy
  • Photochemotherapy*
  • Recurrence
  • Uterine Cervical Dysplasia / drug therapy*
  • Uterine Cervical Dysplasia / virology*
  • Uterine Cervical Neoplasms / drug therapy*
  • Uterine Cervical Neoplasms / virology*

Substances

  • Antineoplastic Agents
  • Antiviral Agents
  • DNA, Viral
  • Dihematoporphyrin Ether